$Semler Scientific (SMLR.US)$🎯 As of April 9, 2024, the cur...

New data: Q4 2023, revenue continues to grow, operating profit shrinks by 26.5% due to gross margin decline, net income grows by 31.3% due to income tax refund impact.

In 2023, revenue increased by 20.3%, operating profit increased by 33.6%, net income increased by 43.7%, with an average net profit growth rate of 13.7% over the past 3 years since going public.

Debt-to-asset ratio decreased from 11.2% to 8%, both total assets and net assets have grown. Cash and accounts receivable on the asset side grew rapidly, while current liabilities on the liability side decreased, with no interest-bearing liabilities.

Currently, the pe ratio is 11, which is significantly discounted compared to the growth rate. Considering the current small revenue scale, it is advisable to choose cautiously (⭐️).